Reactivity of GST-SAPA antigen of Trypanosoma cruzi against sera from patients with Chagas disease and leishmaniasis;Reactividad del antigeno GST-SAPA de trypanosoma cruzi frente a sueros de pacientes con enfermedad de chagas y leishmaniasis

Medicina

Volumn 71, Issue 2, 2011, Pages 113-119

  Gil, Jose ^a   Cimino, Ruben ^a   Quiroga, Ines Lopez ^a   Cajal, Silvana ^a   Acosta, Norma ^a   Juarez, Marisa ^a   Zacca, Rosa ^a   Orellana, Viviana ^a   Krolewiecki, Alejandro ^a   Diosque, Patricio ^a   Nasser, Julio ^a  

^a UNIVERSIDAD NACIONAL DE SALTA   (Argentina)

Author keywords

Chagas; ELISA; Leishmaniasis; SAPA

Indexed keywords

PARASITE ANTIGEN; DIAGNOSTIC AGENT; GLYCOPROTEIN; PROTOZOON ANTIBODY; RECOMBINANT PROTEIN; SIALIDASE; TRANS SIALIDASE; TRANS-SIALIDASE;

ANTIGEN DETECTION; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LEISHMANIASIS; MAJOR CLINICAL STUDY; MIXED INFECTION; PARASITE IDENTIFICATION; SENSITIVITY AND SPECIFICITY; TRYPANOSOMA CRUZI; BLOOD; CROSS REACTION; IMMUNOLOGY; METHODOLOGY; SEROLOGY; SPECIES DIFFERENCE; VISCERAL LEISHMANIASIS;

ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHAGAS DISEASE; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; HUMANS; LEISHMANIASIS, VISCERAL; NEURAMINIDASE; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; SPECIES SPECIFICITY; TRYPANOSOMA CRUZI;

EID: 79958709485     PISSN: 00257680     EISSN: 16699106     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. OPS/OMS. Estimación cuantitativa de la enfermedad de Chagas en las Américas. Montevideo, Uruguay. 2006.
2. Sosa Estani S, Segura E. Tratamiento de la infección por Trypanosoma cruzi en fase indeterminada. Medicina (Buenos Aires) 1999; 59: 166-70.
3. Umezawa E, Nascimento M, Kesper N, et al. Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas' disease. J Clin Microbiol 1996; 34: 2143-47.
4. Caballero Z, Sousa O, Marques W, Saez-Alquezar A, Umezawa E. Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp. Clin Vaccine Immunol 2007; 14: 1045-49.
5. da Silveira JF, Umezawa ES, Luquetti AO. Chagas disease: recombinant Trypanosoma cruzi antigens for serological diagnosis. Trends Parasitol 2001; 17: 286-91.
6. Affranchino J, Ibáñez C, Luquetti A, et al. Identification of a Trypanosoma cruzi antigen that is shed during the phase acute of Chagaśdisease. Mol Biochem Parasitol 1989; 34: 221-8.
7. Reyes M, Lorca M, Muñoz P, Frash A. Fetal IgG specificites against Trypanosoma cruzi antigens in infected newborns. Proc Nati Acad Sci USA 1990; 87: 2846-50.
8. Umezawa E, Silveira F. Serological diagnosis of chagas disease with purified and defined Trypanosoma cruzi antigens. Mem Inst Oswaldo Cruz, Rio de Janeiro 1999; 94.
9. Flores-Chavez M, Bosseno MF, Bastrenta B, et al. Polymerase chain reaction detection and serologic follow-up after treatment with benznidazole in Bolivian children infected with a natural mixture of Trypanosoma cruzi I and II. Am J Trop Med Hyg. 2006; 75: 497-01.
10. Brenière S, Yaksic N, Telleria J, et al. Immune response to Trypanosoma cruzi shed acute phase antigen in children from an endemic area for Chagas disease Bolivia. Mem Inst Oswaldo Cruz, Rio de Janeiro 1997; 92: 503-07.
11. Lorca M, González A, Reyes V, Veloso C, Vergara U, Frasch C. El diagnóstico de la enfermedad de Chagas crónica mediante antígenos recombinantes de Trypanosoma cruzi. Rev Med Chile 1993; 121: 363-68.
12. Vergara U, Lorca M, Veloso C, et al. Assay for detection of Trypanosoma cruzi antibodies in human sera based on reaction with synthetic peptides. J Clin Microbiol 1991; 29: 2034-37.
13. Nasser JR, Gomez LE, Sanchez D, Guerin M, Basombrio MA. Immunogenicity of the recombinant SAPA protein of Trypanosoma cruzi for mice. J Parasitol 1997; 83: 76-1.
14. Passos V, Volpini A, Braga E. Differential serodiagnosis de human infections caused by Trypanosoma cruzi and Leishmania spp. using ELISA with a recombinante antigen (rTc24). Mem Inst Oswaldo Cruz, Rio de Janeiro 1997; 92: 791-93.
15. Cazzulo JJ, Frasch AC. SAPA/trans-sialidase and cruzipain: two antigens from Trypanosoma cruzi contain immunodominant but enzymatically inactive domains. FASEB J 1992; 6: 3259-64.
16. Chiaramonte MG, Zwirner NW, Caropresi SL, Heredia V, Taranto NJ, Malchiodi EL. Estudio de casos de leishmaniasis en la Provincia de Salta: evidencias de infección mixta por Trypanosoma cruzi y Leishmania spp. Medicina (Buenos Aires) 1996; 56: 259-68.
17. Frank FM, Fernandez MM, Taranto NJ, et al. Characterization of human infection by Leishmania spp. in the Northwest of Argentina: immune response, double infection with Trypanosoma cruzi and species of Leishmania involved. Parasitology 2003; 126: 31-9.
18. Bastrenta B, Mita N, Buitrago R, et al. Human Mixed Infections of Leishmania spp. and Leishmania-Trypanosoma cruzi in a Sub Andean Bolivian Area: Identification by Polymerase Chain Reaction/hybridization and Isoenzyme. Mem Inst Oswaldo Cruz, Rio de Janeiro 2003; 98: 255-64.
19. Chiaramonte MG, Zwirner NW, Caropresi SL, Taranto NJ, Malchiodi EL. Trypanosoma cruzi and Leishmania spp. human mixed infection. Am J Trop Med Hyg 1996; 54: 271-73.
20. Malchiodi EL, Chiaramonte MG, Taranto NJ, Zwirner NW, Margni RA. Cross-reactivity studies and differential serodiagnosis of human infections caused by Trypanosoma cruzi and Leishmania spp; use of immunoblotting and ELISA with a purified antigen (Ag163B6). Clin Exp Immunol 1994; 97: 417-23.
21. Davies C, Cimino R, Marco J, Nasser J, Basombrio M. Reactividad del antígeno recombinante SAPA de Trypanososma cruzi frente a sueros de perros de zonas endémicas para las enfermedades de Chagas y leishmaniasis. Medicina (Buenos Aires) 1999; 60: 86.
22. o I3.
23. Diosque P, Padilla AM, Cimino RO, et al. Chagas disease in rural areas of Chaco Province, Argentina: epidemiologic survey in humans, reservoirs, and vectors. Am J Trop Med Hyg 2004; 71: 590-93.
24. Gil JF, Nasser JR, Cajal SP, Juarez M, Acosta N, Cimino RO, Diosque P, Krolewiecki AJ. Urban transmission of american cutaneous leishmaniasis in Argentina: spatial analysis study. Am J Trop Med Hyg 2010; 82: 433-40.
25. Pastini A, Iglesias S, Carncarte V, Guerin M, Sanchez D, Frasch A. Immunoassay with recombinant Trypanosoma cruzi antigens potentially useful for screening donated blood and diagnosing Chagas disease. Clin Chem 1994; 40: 1893-97.
26. Bradford M. A rapid and sensitive method for the quantitative analysis of microgram quantities of protein utilizing the principle of protein dye binding. An Biochem 1976: 248-54.
27. Abraira V. El índice kappa. Notas estadísticas 2000; 27: 247-49.
28. Mallimaci MC, Sosa-Estani S, Russomando G, et al. Early diagnosis of congenital Trypanosoma cruzi infection, using shed acute phase antigen, in Ushuaia, Tierra del Fuego, Argentina. Am J Trop Med Hyg 82: 55-9.
29. Di Noia JM, Buscaglia CA, De Marchi CR, Almeida IC, Frasch AC. A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage. J Exp Med 2002; 195: 401-13.
30. Umezawa E, Luquetti A, Levitus G, et al. Serodiagnosis of chronic and acute Chagas' disease with Trypanosoma cruzi recombinant proteins: results of a collaborative study in six Latin American countries. J Clin Microbiol 2004; 42: 449-52.
31. Machado EM, Fernandes AJ, Murta SM, et al. A study of experimental reinfection by Trypanosoma cruzi in dogs. Am J Trop Med Hyg 2001; 65: 958-65.
32. Monteon V, Guzman-Bracho C, Florián-Verdugo J, Ramos-Hecheverria A, Velasco-Castrejon Reyes P. Diagnóstico serológico de la enfermedad de Chagas: autosuficiencia y concordancia interlaboratorios. Salud Púb Mex 1995; 37: 232-35.
33. López de Ullibarri Galparsoro I, Pita Fernández S. Medidas de concordancia: el índice de Kappa. Cad Aten Primaria 1999; 6: 169-71.
34. García M, Cabezas C, Martos L, Gonzáles A, Acosta R. Determinación de anticuerpos IgM contra el virus denge a partir de sangre absorbida en papel de filtro: un método alternativo y sencillo. Rev Med Exp 2000; 17: 1-4.
35. Sosa-Jurado F, Zumaquero-Ríos J, Reyes P. Factores bióticos y abióticos que determinan la seroprevalencia de anticuerpos contra Trypanosoma cruzi en el municipio de Palmar de Bravo, Puebla, México. Salud Publ Méx 2004; 46: 39-8.
36. Landis J, Koch G. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74.
37. de Andrade A, Zicker F, Luquetti A, et al. Surveillance of Trypanosoma cruzi transmission by serological screening of schoolchildren. Bull World Health Organ 1992; 70: 625-29.